What is the market cap difference between JNJ and ABBV?

JNJ has a market cap of $577.5B and ABBV has a market cap of $410.8B. JNJ has a 1.4x larger market capitalization than ABBV

JNJ vs ABBV Stock Comparison

Compare Johnson & Johnson (JNJ) and AbbVie Inc. (ABBV) side by side. View price, valuation, dividends, and financial metrics.

Johnson & Johnson

$239.63-0.38%

Healthcare / Drug Manufacturers - General · $577.5B market cap

AbbVie Inc.

$232.35-1.63%

Healthcare / Drug Manufacturers - General · $410.8B market cap

Both JNJ and ABBV operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.

JNJ has a 1.4x larger market capitalization than ABBV.

JNJ trades at a lower P/E ratio (21.7x) compared to ABBV (98.0x), suggesting JNJ may be more attractively valued relative to its earnings.

ABBV offers a higher dividend yield (2.98%) vs JNJ (2.17%), making it more attractive for income investors.

Looking at profitability, JNJ has a profit margin of 2845.8% while ABBV's is 684.4%. JNJ converts more of its revenue into profit.

In terms of growth, JNJ has revenue growth of 9.1% versus 10.0% for ABBV. ABBV is growing its top line faster.

Which is a better investment, JNJ or ABBV?: Both stocks have different strengths. Johnson & Johnson (JNJ) trades at $239.63 with a $577.5B market cap, while AbbVie Inc. (ABBV) trades at $232.35 with a $410.8B market cap. JNJ trades at a lower P/E ratio (21.7x) compared to ABBV (98.0x), suggesting JNJ may be more attractively valued relative to its earnings. The better choice depends on your investment goals, time horizon, and risk tolerance.
Are JNJ and ABBV in the same sector?: Both JNJ and ABBV operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.
Do JNJ and ABBV pay dividends?: ABBV offers a higher dividend yield (2.98%) vs JNJ (2.17%), making it more attractive for income investors.